Central blood pressure: A new vital sign?

Artery Research

Volumn 3, Issue 4, 2009, Pages 125-127

  Roman, Mary J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Applanation tonometry; Atherosclerosis; Cardiovascular disease outcomes; Central blood pressure; Left ventricular hypertrophy

Indexed keywords

ATHEROSCLEROSIS; BLOOD PRESSURE; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PULSE WAVE; SHORT SURVEY; SYSTOLIC BLOOD PRESSURE; VITAL SIGN;

EID: 70849129741     PISSN: 18729312     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.artres.2009.10.179     Document Type: Short Survey

References (24)

1. Hlatky M.A., Greenland P., Arnett D.K., Ballantyne C.M., Criqui M.H., Elkind M.S.V., et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119 (2009) 2408-2416
2. Kelly R., Hayward C., Ganis J., Daley J., Avolio A., and O'Rourke M. Noninvasive registration of the arterial pressure waveform using high-fidelity applanation tonometry. J Vasc Med Biol 1 (1989) 142-149
3. Chen C.-H., Ting C.T., Nussbacher A., Nevo E., Kass D.A., Pak P., et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension 27 (1996) 168-175
4. Pauca A.L., O'Rourke M.F., and Kon N.D. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38 (2001) 932-937
5. Siebenhofer A., Kemp C.R.W., Sutton A.J., and Williams B. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens 13 (1999) 625-629
6. Lane D., Beevers M., Barnes N., Bourne J., John A., Malins S., et al. Inter-arm differences in blood pressure: when are they clinically significant?. J Hypertens 20 (2002) 1089-1095
7. Lee E.T., Welty T.K., Fabsitz R.R., Cowan L.D., Lee N.-A., Oopik A.J., et al. The Strong Heart Study: a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 132 (1990) 1141-1155
8. Fox C.S., Coady S., Sorlie P.D., D'Agostino Sr. R.B., Pencina M.J., Ramachandran R.S., et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 115 (2007) 1544-1550
9. Roman M.J., Devereux R.B., Kizer J.R., Lee E.T., Galloway J.M., Ali T., et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 50 (2007) 197-203
10. Roman MJ, Okin PM, Kizer JR, Lee ET, Howard BV, Devereux RB. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study. J Hypertens, in press.
11. de Simone G., Kizer J.R., Chinali M., Roman M.J., Bella J.N., Best L.G., et al. Normalization for body size and the population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens 18 (2005) 191-196
12. de Simone G., Devereux R.B., Daniels S.R., Koren M.J., Meyer R.A., and Laragh J.H. Effect of growth on variability of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25 (1995) 1056-1062
13. Chen C.-H., Ting C.-T., Lin S.-J., His T.-L., Ho S.-J., Chou P., et al. Which arterial and cardiac parameters best predict left ventricular mass?. Circulation 98 (1998) 422-428
14. Flack J.M., Gardin J.M., Yunis C., and for the CARDIA Research Group. Static and pulsatile blood pressure correlates of left ventricular structure and function in black and white young adults: the Cardia Study. Am Heart J 138 (1999) 856-864
15. Verdecchia P., Schillaci G., Borgioni C., Gaatobigio R., Ambrosio G., and Porcellati C. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension. Eur Heart J 23 (2002) 658-665
16. Wang K.-L., Cheng H.-M., Chuang S.-Y., Spurgeon H.A., Ting C.-T., Lakatta E.G., et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?. J Hypertens 27 (2009) 461-467
17. Pini R., Cavallini M.C., Palmieri V., Marchionni N., Di Bari M., Devereux R.B., et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 51 (2008) 2432-2439
18. Roman M.J., Devereux R.B., Kizer J.R., Okin P.M., Lee E.T., and Wang W. High central pulse pressure is independently associated with adverse cardiovascular outcome: the Strong Heart Study. J Am Coll Cardiol 54 (2009) 1730-1734
19. Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W. High central pulse pressure is independently associated with adverse cardiovascular outcome: the Strong Heart Study. J Am Coll Cardiol, 2009; 54:1730--4.
20. De Luca N., Asmar R.G., London G.M., O'Rourke M.F., Safar, and on behalf of the REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens 22 (2004) 1623-1630
21. Poulter N.R., Weddel H., Dahlof B., Sever P.S., Beevers D.G., Caulfield M., et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the anglo-scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA). Lancet 366 (2005) 907-913
22. The CAFÉ Investigators, and for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the conduit artery function evaluation (CAFÉ) study. Circulation 113 (2006) 1213-1225
23. Dahlof B., Devereux R.B., Kjeldsen S.E., Julius S., Beevers G., de Faire U., et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 995-1003
24. McEniery C.B.M., Yasmin M.B., Munnery M., Wallace S.M., Rowe C.V., et al., on Behalf of the Anglo-Cardiff Collaborative Trial Investigators. Central pressure: variability and impact of cardiovascular risk factors: the anglo-cardiff collaborative trial II. Hypertension 51 (2008) 1476-1482